Anti-Human CD22 Recombinant Antibody(Epratuzumab)
-
产品编号
YR1021
-
别名
科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab |
Catalog Number | YR1021 |
Molecular Name | Epratuzumab |
Host | Mouse |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 |
Formulation | PBS, pH7.5 |
Background | Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE). |
CAS Number | 205923-57-5 |
Application | IF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD22[Homo sapiens] |